a public good project by the
Synthesis
Company
of California

© 2026

Danhong Wu | doi.page

0 works0 citations0 h-index

Danhong Wu

Fudan University(CN)Obstetrics and Gynecology Hospital of Fudan University(CN)East China Normal University(CN)

Publications by Year

Research Areas

Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Intracerebral and Subarachnoid Hemorrhage Research, Dementia and Cognitive Impairment Research, Antioxidant Activity and Oxidative Stress

Most-Cited Works

→ Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders(2021)53 cited
→ Tenecteplase Thrombolysis for Stroke up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial(2025)33 cited
→ ADAMTS13: An Emerging Target in Stroke Therapy(2019)32 cited
→ Association of Cerebral Microbleeds with Cognitive Decline: A Longitudinal Study(2020)31 cited
→ The oral microbiome of patients with ischemic stroke predicts their severity and prognosis(2023)26 cited
→ Poly(ADP-ribose) polymerase mediates both cell death and ATP decreases in SIRT2 inhibitor AGK2-treated microglial BV2 cells(2013)22 cited

→ Tongxinluo and Functional Outcomes Among Patients With Acute Ischemic Stroke(2024)

21 cited

→ Extracellular Degradation Into Adenosine and the Activities of Adenosine Kinase and AMPK Mediate Extracellular NAD+-Produced Increases in the Adenylate Pool of BV2 Microglia Under Basal Conditions(2018)19 cited

→ Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial(2024)18 cited

→ Embryonic Surface Ectoderm-specific Mitofusin 2 Conditional Knockout Induces Congenital Cataracts in Mice(2018)17 cited